Phosphodiesterase 5 inhibition restores impaired ACh relaxation in hypertensive conduit pulmonary arteries.
- 1 March 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 280 (3) , L432-L435
- https://doi.org/10.1152/ajplung.2001.280.3.l432
Abstract
Responses to acetylcholine (ACh) and sodium nitroprusside (SNP) were compared in large (LPA) and small pulmonary artery (SPA) rings from normoxic and chronically hypoxic (CH) rats. In addition, the effects of a selective phosphodiesterase (PDE) 5 inhibitor, E-4021, on ACh-induced relaxation were evaluated. Chronic hypoxia markedly decreased both ACh- and SNP-induced relaxations in LPA but not in SPA rings. Pretreatment with E-4021 caused a much greater leftward shift of the concentration-response curve for ACh in hypoxic than in normoxic LPA rings, eliminating the difference in response to ACh between these two vessels. These results suggest that cGMP-dependent relaxation is impaired in the proximal but not in the distal pulmonary artery of CH rats and that increased PDE5 activity could be a mechanism responsible for this impaired responsiveness.Keywords
This publication has 11 references indexed in Scilit:
- Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1999
- E4021, a Selective Phosphodiesterase 5 Inhibitor, Potentiates the Vasodilator Effect of Inhaled Nitric Oxide in Isolated Perfused Rat LungsJournal of Cardiovascular Pharmacology, 1999
- Effects of a novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigsEuropean Journal of Pharmacology, 1994
- Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1994
- Hemodynamic and Gas Exchange Responses to Infusion of Acetylcholine and Inhalation of Nitric Oxide in Patients with Chronic Obstructive Lung Disease and Pulmonary HypertensionAmerican Review of Respiratory Disease, 1993
- Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease.Circulation Research, 1993
- BQ123, an ETA Receptor Antagonist, Attenuates Endothelin-1-Induced Vasoconstriction in Rat Pulmonary CirculationJournal of Cardiovascular Pharmacology, 1993
- Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive ratsBritish Journal of Pharmacology, 1992
- Impairment of Endothelium-Dependent Pulmonary-Artery Relaxation in Chronic Obstructive Lung DiseaseNew England Journal of Medicine, 1991
- Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertensionJournal of Applied Physiology, 1988